At Novartis, Fishman Finds a Winning Formula

January 4, 2011

January 4, 2011 | Nine years after his appointment as president of the Novartis Institute for Biomedical Research (NIBR), while other companies are scaling back drug development, cardiologist Mark Fishman, 58, is overseeing an expansion of Novartis research in the U.S. and around the world. (Bio-IT World covered the relaunch of NIBR in Cambridge, Mass., in 2004.) Boston Globe